Stem cell-based multi-tissue platforms to model human autoimmune diabetes
Background: Type 1 diabetes (T1D) is an autoimmune disease in which pancreatic insulin-producing β cells are specifically destroyed by the immune system. Understanding the initiation and progression of human T1D has been hampered by the lack of appropriate models that can reproduce the complexity an...
Saved in:
Main Authors: | Karla F. Leavens (Author), Juan R. Alvarez-Dominguez (Author), Linda T. Vo (Author), Holger A. Russ (Author), Audrey V. Parent (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stem Cell Derived Organoids in Human Disease and Development
by: Stefan Liebau, et al.
Published: (2019) -
Primary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives
by: A.G. Ziegler, et al.
Published: (2016) -
Modeling Human Brain Circuitry Using Pluripotent Stem Cell Platforms
by: Annalisa M. Hartlaub, et al.
Published: (2019) -
Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
by: Shiri Li, et al.
Published: (2021) -
Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease
by: Chongjun Xiao, et al.
Published: (2021)